↓ Skip to main content

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis

Overview of attention for article published in Journal of Hematology & Oncology, March 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
4 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
67 Mendeley